The global industry focuses on producing and selling high-titer antibodies derived from vaccinated or convalescent human plasma, specifically used for treating or preventing diseases such as rabies, tetanus, and hepatitis B. Hyperimmune globulins are concentrated, purified immunoglobulin (antibody) preparations derived from the plasma of human donors with high antibody titers against specific diseases, providing immediate, short-term passive immunity. There is an increasing global burden of infectious diseases like hepatitis B, rabies, and tetanus, where immediate passive immunity is crucial for prevention and cure.

There is an increasing demand for hyperimmune globulin across industrial, commercial, and technology-driven applications, along with continuous innovation and investment across major end-use sectors. Key companies are also expanding their product offerings and launching novel products.

The global industry focuses on producing and selling high-titer antibodies derived from vaccinated or convalescent human plasma, specifically used for treating or preventing diseases such as rabies, tetanus, and hepatitis B. Hyperimmune globulins are concentrated, purified immunoglobulin (antibody) preparations derived from the plasma of human donors with high antibody titers against specific diseases, providing immediate, short-term passive immunity. There is an increasing global burden of infectious diseases like hepatitis B, rabies, and tetanus, where immediate passive immunity is crucial for prevention and cure.